로딩 중…
지수 로딩 중…
Voyager Therapeutics Inc. Common Stock
VYGR· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$3.72+2.76%
2026-06-18
Price Chart
Voyager Therapeutics Inc. Common Stock+22.37%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $225M |
| Revenue | $36M |
| Net Income | $-117M |
| Total Assets | $219M |
| Net Assets | $174M |
| Value | |
| P/B | 1.29x |
| P/S | 6.16x |
| FCF Yield | -57.81% |
| Profitability | |
| ROE | -67.16% |
| ROA | -53.18% |
| Op. Margin | -349.16% |
| Revenue Growth | -59.94% |
| Financial Health | |
| Debt Ratio | 26.29% |
| Total Debt | $35M |
| FCF | $-130M |
| Cash | $43M |
| Current Ratio | 8.42x |
| Performance | |
| 1Y Return | 22.37% |
| 1M Return | 6.90% |
| From 52W High | -32.97% |
| 1Y MDD | -37.71% |
| Trading | |
| Volume | 640,056 shares |
| Trading Value | $2M |